The Pancreatic Cancer Marker
CA 19-9 is most closely associated with pancreatic cancer—it's the best blood marker available for this devastating disease, though it's far from perfect. It's also elevated in other GI cancers and in benign biliary obstruction. About 5-10% of people (those who are Lewis antigen negative) can't produce CA 19-9 at all.
What is CA 19-9?
CA 19-9 is a sialylated Lewis blood group antigen (carbohydrate). Normal: <37 U/mL. Not produced by Lewis antigen-negative individuals (~5-10%). Primary use: monitoring pancreatic cancer treatment response. Sensitivity ~80% for pancreatic cancer, but specificity is limited.
↑ What High CA 19-9 Means
Concerning for pancreatic cancer, especially if >100 U/mL. But biliary obstruction from any cause (gallstones, cholangitis) can markedly elevate CA 19-9. Other GI cancers (colorectal, gastric, cholangiocarcinoma) also raise it.
Common symptoms:
Often asymptomatic early (why pancreatic cancer is deadly) · Jaundice (yellowing), weight loss, abdominal/back pain, new-onset diabetes · If biliary: right upper quadrant pain, jaundice
↓ What Low CA 19-9 Means
Reassuring. Note: 5-10% of population are Lewis antigen negative and produce no CA 19-9 regardless of cancer.
Common symptoms:
No symptoms
Why It Matters
When normal:
Best available blood marker for pancreatic cancer
Monitors treatment response and recurrence
Prognostic in pancreatic cancer
Helps distinguish malignant from benign biliary obstruction
Risks if abnormal:
Not recommended for screening (insufficient sensitivity/specificity)
Elevated by benign biliary obstruction
5-10% can't produce CA 19-9 (Lewis negative)
What Can Cause Abnormal Levels?
Pancreatic Cancer
30% likely~80% sensitivity. CA 19-9 >300 U/mL in suspected pancreatic cancer is highly suggestive.
Biliary Obstruction (benign)
35% likelyGallstones causing bile duct obstruction can dramatically elevate CA 19-9.
Cholangiocarcinoma
Bile duct cancer elevates CA 19-9.
Other GI Cancers
Colorectal, gastric, hepatocellular carcinoma.
Pancreatitis
Acute and chronic pancreatitis elevate CA 19-9.
Liver Disease
Cirrhosis and hepatitis.
What You Can Do
CA 19-9 is a monitoring marker, not for screening
Impact: Interpret in clinical context \u00B7 Timeline: N/A
If elevated with biliary obstruction: relieve obstruction first, then recheck
Impact: Obstruction alone markedly raises CA 19-9 \u00B7 Timeline: 2-4 weeks post-drainage
If lifestyle changes aren't enough:
Cross-sectional imaging (CT/MRI) if elevated without benign explanation
Impact: Evaluates pancreas and biliary system \u00B7 Timeline: Urgent
Recommended retest: Cancer monitoring: per treatment protocol
Got your blood test report?
Upload your PDF and understand ALL your markers in 2 minutes. Plain language. Traffic light status. No medical jargon.
Analyze My Report — FreeFirst report is free. No credit card needed.